Suchergebnisse - "Exemestane"

PubPharm (1.416)

51

A simple UPLC-MS/MS assay with a core-shell column for the determination of exemestane in human plasma for clinical application

enthalten in: European journal of mass spectrometry (Chichester, England) | 2022

von Ishii, T. | Nojiri, N. | Mano, Y.

52

Everolimus and exemestane in hormone receptor positive advanced breast cancer : A comprehensive cancer center's experience

enthalten in: Bulletin du cancer | 2022

von Moreira, I. | Afonso, A. | Abreu, M. | +2

53

Magnetic mesoporous silica nanoparticles as a theranostic approach for breast cancer : Loading and release of the poorly soluble drug exemestane

enthalten in: International journal of pharmaceutics | 2022

von Laranjeira, M. | Ribeiro, T. | Magalhães, A. | +3

54

From clinical trials to clinical practice : the use of everolimus and exemestane in the treatment of hormone receptor-positive metastatic breast cancer: real-world data

enthalten in: Journal of chemotherapy (Florence, Italy) | 2022

von Abdel-Razeq, H. | Sharaf, B. | Abdulelah, H. | +4

55

Simultaneous Quantification of Aromatase Inhibitors and Estrogens in Postmenopausal Breast Cancer Patients

enthalten in: The Journal of clinical endocrinology and metabolism | 2022

von Bertelsen, B. | Viste, K. | Helland, T. | +8

56

Real-World Outcomes of Everolimus and Exemestane for the Treatment of Metastatic Hormone Receptor-Positive Breast Cancer in Patients Previously Treated With CDK4/6 Inhibitors

enthalten in: Clinical breast cancer | 2022

von Mo, H. | Renna, C. | Moore, H. | +6

57

Updates in hormone-receptor-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced breast cancer in 2021

enthalten in: Bulletin du cancer | 2022

von Mezni, E. | Sabatier, R. | Goncalves, A. | +1

58

Real-Life Analysis of Efficacy and Safety of Everolimus Plus Exemestane in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor-2-Negative Metastatic Breast Cancer Patients : A Turkish Oncology Group (TOG) Study

enthalten in: Cancer investigation | 2022

von Bilici, A. | Uysal, M. | Menekse, S. | +25

59

Role of Exemestane in the Treatment of Estrogen-Receptor-Positive Breast Cancer : A Narrative Review of Recent Evidence

enthalten in: Advances in therapy | 2022

von Wang, Y. | Jing, F. | Wang, H.

60

A Phase Ib Dose Escalation Trial of RO4929097 (a γ-secretase inhibitor) in Combination with Exemestane in Patients with ER + Metastatic Breast Cancer (MBC)

enthalten in: Clinical breast cancer | 2022

von Means-Powell, J. | Mayer, I. | Ismail-Khan, R. | +8